When prescribing or dispensing unregistered medicines, understanding how patient medications are monitored across Australia is an important part of safe and compliant clinical practice.

Real-Time Prescription Monitoring (RTPM) systems give prescribers and pharmacists access to information about a patient’s monitored medicine history to support informed clinical decisions.

In our latest article, we break down the different systems across Australia, how the traffic-light alerts work, and why RTPM is a clinical decision-support tool — not a barrier to patient care.

Compliance doesn't stop with clinics and prescribers. In Part Two of our TGA reporting series, we break down the record-keeping and reporting obligations for importers, pharmacies, manufacturers and sponsors.

As regulators share more data and close reporting gaps, businesses that treat compliance as a strategic priority will be best placed for sustainable growth.

Navigating medicinal cannabis compliance in Australia requires more than meeting initial regulatory approvals. As the Therapeutic Goods Administration (TGA) increases its focus on reporting, governance, pharmacovigilance and advertising compliance, businesses must implement strong systems to remain compliant. Learn the essential reporting obligations and best practices for operating successfully in Australia's evolving medicinal cannabis market.

Medicinal cannabis in Australia is rapidly evolving — where what was once a niche market is now a significant part of modern healthcare. For businesses navigating this landscape, understanding these dual pressures is key to thriving in this fast-paced and dynamic environment.

In the latest addition to our Market Insights series that explores the Australian medicinal cannabis space, we look into patient demographics and how patients access plant-based medicines.